MedPath

Investigating the effect of nandrolone on the quality of life

Phase 3
Recruiting
Conditions
Heart failure.
Heart failure
Registration Number
IRCT20231116060079N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
90
Inclusion Criteria

Women with heart failure FCII and FCIII
Ejection Fraction less than and equal to 40
Age over 50 years

Exclusion Criteria

Occurrence of ischemia in the last 6 months of the disease
Hormonal disorders
Consumption of oral contraceptive pill (OCP)
Hypertension

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of Life. Timepoint: Before and six weeks after the intervention. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
Cardiac ejection fraction. Timepoint: Before and six weeks after the intervention. Method of measurement: Eco-cardiography.
© Copyright 2025. All Rights Reserved by MedPath